Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Health Italia SpA's Debt-to-EBITDA or its related term are showing as below:
MIL:HI'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.14 Med: 2.08 Max: 4.84
Current: 1.37
During the past 10 years, the highest Debt-to-EBITDA Ratio of Health Italia SpA was 4.84. The lowest was 0.14. And the median was 2.08.
MIL:HI's Debt-to-EBITDA is not ranked
in the Healthcare Plans industry.
Industry Median: 2.86
vs MIL:HI: 1.37
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Health Italia SpA Debt-to-EBITDA Related Terms
Health Italia SpA Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Health Italia SpA's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Healthcare Plans subindustry, Health Italia SpA's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Health Italia SpA Debt-to-EBITDA vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, Health Italia SpA's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Health Italia SpA's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is two times the quarterly (Jun. 2025) EBITDA data.
Health Italia SpA (MIL:HI) has a Debt-to-EBITDA of 1.19 as of Jun. 2025. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Health Italia SpA. This is 43% below median its historical median of 2.08. Over the past decade, Health Italia SpA's Debt-to-EBITDA has ranged from 0.14 to 4.84.
Is Health Italia SpA's Debt-to-EBITDA too high?
Health Italia SpA's current Debt-to-EBITDA of 1.19 is 43% below median its 10-year median of 2.08. Over the past 10 years, this metric has ranged from a low of 0.14 to a high of 4.84. The Healthcare Plans industry median Debt-to-EBITDA is 2.86. Health Italia SpA's value of 1.19 is 58.4% below this industry median. Overall, Health Italia SpA has a GF Score™ of 43/100, reflecting its overall financial health beyond just this single metric.
How does Health Italia SpA's Debt-to-EBITDA compare to UNH and CVS?
Health Italia SpA's Debt-to-EBITDA of 1.19 can be compared against companies in the Healthcare Plans industry. The industry median Debt-to-EBITDA is 2.86. Health Italia SpA's value of 1.19 is 58.4% below this benchmark. Historically, Health Italia SpA's own Debt-to-EBITDA has ranged from 0.14 to 4.84 over the past decade. While the company's 10-year median is 2.08 vs. the industry median of 2.86, Health Italia SpA has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Plans company?
The median Debt-to-EBITDA among Healthcare Plans companies is 2.86, based on 13 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Health Italia SpA's current Debt-to-EBITDA of 1.19 is 58.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Health Italia SpA. For the Healthcare Plans industry, the median Debt-to-EBITDA is 2.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Health Italia SpA's current Debt-to-EBITDA is 1.19, which is 43% below median its own 10-year median of 2.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Health Italia SpA stock overvalued right now?
Health Italia SpA (MIL:HI) has a current Debt-to-EBITDA of 1.19. The stock's GF Value™ is €142.57, compared to a current price of €299.00 — trading 109.7% above its estimated fair value. The current Debt-to-EBITDA is 1.19, which is 43% below median its 10-year median of 2.08 and 58.4% below the Healthcare Plans industry median of 2.86. Health Italia SpA's overall GF Score™ is 43/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Health Italia SpA (MIL:HI), the current Debt-to-EBITDA is 1.19 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Health Italia SpA (MIL:HI) Overvalued in 2026?
Based on GuruFocus' analysis, Health Italia SpA stock appears to be overvalued.
The current stock price of €299.00 is trading 109.7% above its estimated GF Value™ of €142.57.
Key valuation signals for MIL:HI:
Debt-to-EBITDA: 1.19 (43% below median its 10-year median of 2.08)
GF Value™: €142.57 vs. price of €299.00 (109.7% above fair value)
Industry Position: 58.4% below the Healthcare Plans median
No single metric tells the full story. See the MIL:HI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Health Italia SpA is an Italy based company engaged in offering integrated healthcare services. It operates in the promotion of integrated and alternative healthcare solutions and provides administrative, liquidation, information technology and consulting services for health funds, health care funds and mutual-aid companies. In addition, the group is also active in the corporate welfare market and manages outsourced flexible benefit welfare plans.
43GF Score
Get the complete analysis for MIL:HI
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:HI has been successfully added to your 
